How This Evidence Evolved
Achalasia Treatment
From Pneumatic Dilation to POEM: Evolving Interventions for Esophageal Motility Disorders
Timeline
Early observations and pilot data that first suggested a new direction
Landmark RCTs and pivotal trials that established the evidence base
Dysphagia score after POEM: 10 vs 1.3 (P=0.0003); LES pressure 52.4 vs 19.9 mmHg (P=0.0001); no serious POEM-related complications; 17 patients
10-year reported LHM n=40, PD n=36; full-analysis success 74% vs 74% (P=.84); per-protocol 74% vs 86% (P=.07).
Follow-up studies, subgroup analyses, and real-world validation
Integration into clinical practice guidelines and recommendations
Definitive-therapy candidates: PD/LHM/POEM for types I/II; tailored POEM/LHM for type III.
POEM and LHM give comparable symptom relief; counsel higher GERD risk after POEM vs LHM with fundoplication or PD.
Current standard of care and ongoing research directions
Landmark Trials in This Story
Pneumatic dilation versus laparoscopic Heller's myotomy for idiopathic achalasia
Therapeutic success (Eckardt score ≤3) at 2 years — LHM 90% vs pneumatic dilation 86% (NS)
Peroral endoscopic myotomy (POEM) for esophageal achalasia
Dysphagia score after POEM: 10 vs 1.3 (P=0.0003); LES pressure 52.4 vs 19.9 mmHg (P=0.0001); no serious POEM-related complications; 17 patients
10-year follow-up results of the European Achalasia Trial: a multicentre randomised controlled trial comparing pneumatic dilation with laparoscopic Heller myotomy.
10-year reported LHM n=40, PD n=36; full-analysis success 74% vs 74% (P=.84); per-protocol 74% vs 86% (P=.07).
Endoscopic or Surgical Myotomy in Patients with Idiopathic Achalasia
Clinical success at 2 years: POEM 83.0% vs LHM 81.7% (p=0.007 for noninferiority); endoscopic reflux esophagitis: 44% vs 29%
Explore the evidence yourself
Ask AttendMe about any trial, guideline, or clinical question. Evidence-ranked answers from 3.7M+ peer-reviewed articles.